L

LSP

Description

LSP is a defense & space company that offers strategy consulting services.

Investor Profile

LSP has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • Belgium (50%)
  • France (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LSP frequently co-invest with?

CA
Europe, Rhone-Alpes, France, Champagne-au-mont-d'or
Co-Investments: 1
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
China Grand Pharmaceutical and Healthcare Holdings
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 1
Novalis LifeSciences
North America, Virginia, United States, Hampton
Co-Investments: 1
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Yijing Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 1
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
BNP Paribas Private Equity
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by LSP?

etherna immunotherapies

Niel, Antwerpen, Belgium

etherna develops mRNA and lipid nanoparticle solutions.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series BJun 16, 2020
Amount Raised: $38,306,104
Amolyt Pharma

Écully, Rhone-Alpes, France

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

BiotechnologyHealth CareMedicalPharmaceuticalWellness
Series AJul 31, 2019
Amount Raised: $74,180,691